In one of the most far-reaching changes to Pakistan's higher education admission system in recent years, Higher Education Commission Pakistan has centralised the MPhil and PhD admission process by ...

EAU CLAIRE COUNTY, Wis. (WEAU) - The Eau Claire County Highway Department is announcing County Highway D in the Town of Clear Creek will be closed for multiple culvert removals and replacements. A map ...

Higher Education Commission has introduced a fully online and paperless Degree Attestation System (DAS), allowing students and graduates across Pakistan to apply for degree attestation without ...

HEC online degree attestation is now live, and if you have been dreading the process of getting your degree attested for overseas employment, further studies, or visa applications, the new system ...

The Higher Education Commission of Pakistan (HEC) on Monday announced the launch of a “fully online and paperless” degree attestation system to facilitate students. In December last year, the HEC said ...

A new drug called daraxonrasib is giving fresh hope to people with pancreatic cancer, a disease that's been tough to treat. In a big clinical trial shared at a recent cancer research conference, the ...

EAU CLAIRE COUNTY, Wis. (WEAU) - The Eau Claire County Highway Department is announcing that CTH U in the Town of Clear Creek and Town of Pleasant Valley will be closed for multiple culvert removals ...

After debunking earlier rumors that it was acquiring RAS superstar Revolution Medicines, AbbVie is now taking a more definitive step into the red-hot cancer field. The Chicago pharma has agreed to ...

Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.

State Key Laboratory of Neurology and Oncology Drug Development, Simcere Zaiming Pharmaceutical Co, Ltd., Shanghai, China.

REDWOOD CITY, Calif., March 17, 2026 (GLOBE NEWSWIRE)-- Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...